Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012168 · ClinicalTrials.gov registry record · NA
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
NCT00012168 is a NA study that has completed, run by NYU Langone Health.
The verdict
NCT00012168, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
Interventions
- GENETIC polymerase chain reaction
- OTHER immunohistochemistry staining method
- PROCEDURE radionuclide imaging
- PROCEDURE lymphangiography
- DRUG isosulfan blue
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00012168
The ClinicalTrials.gov registry entry for NCT00012168 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which polymerase chain reaction is the first listed.
NCT00012168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00012168 about?
NCT00012168 is a clinical study titled "Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat". RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node met...
What is the current status of trial NCT00012168?
This trial is currently completed. It is a NA study. The study started on 1999-05.
What interventions are being tested in trial NCT00012168?
The interventions under investigation include: polymerase chain reaction (GENETIC), immunohistochemistry staining method (OTHER), radionuclide imaging (PROCEDURE), lymphangiography (PROCEDURE), isosulfan blue (DRUG).
Who is sponsoring clinical trial NCT00012168?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.